Plavix

I never heard the end of the story, but it illustrated very well how the nurses, who may be the principle health care providers in many of the islands can be caught without proper equipment or backup. Plavix update october 2006 - bristol-myers squibb had third-quarter earnings in 2006 plunge as sales of the anti-clotting drug plavix were hurt by a cheaper generic. DESCRIPTION: Code indicates charges for drugs and biologicals requiring specific identification as required by the payer. If a HCPCS is used to describe the drug, enter the HCPCS code in FL 44. SUBCATEGORY: STANDARD ABBREVIATION: 0 RESERVED EFFECTIVE 01 98 ; Single Source Drug DRUG SNGLE 2 Multiple Source Drug DRUG MULT 3 Restrictive Prescription DRUG RSTR 4 Erythropoietin EPO ; less than 10, 000 units DRUG EPO 10, 000 Units 5 Erythropoietin EPO ; 10, 000 or more units DRUG EPO 10, 000 Units 6 Drugs Requiring Detailed Coding * DRUG DETAIL CODE 7 Self-Administerable Drugs DRUG SELFADMIN.
The provisions relating to a payment to apotex in the event sales of plavix * were lower than specified amounts and to a payment to apotex in the event the required antitrust clearances were not obtained also were deleted. BRITISH NATIONAL FORMULARY 1997 ; British National Formulary. London: British Medical Association and the Royal Pharmaceutical Society of Great Britain. CHAPLIN, R. 1998 ; Informing patients about tardive dyskinesia. Controlled trial of patient education. BritishJournal of Psychiatry, 172, 78 81. The two ph buffer systems namely ph 4 and ph 8 were selected only to mimic the conditions in the small intestine and colon and they did not have any effect on the drug release mechanism and plendil. CELEBREX 100 MG CAPSULE CELEBREX 100 MG CAPSULE ACYCLOVIR 200 MG CAPSULE IPRATROPIUM 0.03% SPRAY LIPITOR 10 MG TABLET LIPITOR 10 MG TABLET PHENOBARBITAL 30 MG TABLET PHENOBARBITAL 30 MG TABLET PHENOBARBITAL 30 MG TABLET GLYBURIDE-METFORMIN 5 500 MG GLYBURIDE-METFORMIN 5 500 MG PLAVIX 75 MG TABLET BACIT-POLYMYXIN EYE OINT BIAXIN 500 MG TABLET CLARINEX 5 MG TABLET CLARINEX 5 MG TABLET LEVAQUIN 250 MG TABLET LEVAQUIN 500 MG TABLET LEVAQUIN 500 MG TABLET LEVAQUIN 500 MG TABLET MOBIC 7.5 MG TABLET TORADOL 10 MG TABLET ACIPHEX 20 MG TABLET EC AMBIEN 5 MG TABLET AMBIEN 5 MG TABLET ATENOLOL 25 MG TABLET LISINOPRIL 40 MG TABLET LOVASTATIN 20 MG TABLET LOVASTATIN 40 MG TABLET LOVASTATIN 40 MG TABLET NIFEDIPINE ER 60 MG TABLET ZETIA 10 MG TABLET ZYRTEC-D TABLET ZYRTEC-D TABLET DICLOFENAC SOD 25 MG TAB EC METFORMIN HCL 850 MG TABLET METFORMIN HCL 850 MG TABLET DILTIAZEM HCL 360 MG CAP SA BENZOYL PEROXIDE 10% WASH CAPTOPRIL 50 MG TABLET CAPTOPRIL 50 MG TABLET E.E.S. 400 MG 5 ML SUSPENSION E.E.S. 200 MG 5 ML SUSPENSION CLONAZEPAM 2 MG TABLET FLUCONAZOLE 150 MG TABLET SINGULAIR 10 MG TABLET GABAPENTIN 300 MG CAPSULE GABAPENTIN 300 MG CAPSULE GABAPENTIN 300 MG CAPSULE GABAPENTIN 400 MG CAPSULE GABAPENTIN 400 MG CAPSULE PROPRANOLOL 20 MG TABLET CEFACLOR 375 MG 5 ML SUSPEN CEFACLOR 375 MG 5 ML SUSPEN CEFACLOR 500 MG CAPSULE PRIMIDONE 50 MG TABLET NASACORT AQ NASAL SPRAY GABAPENTIN 100 MG CAPSULE. Other drugs order aciphex order actos order altace order amaryl order antabuse order aralen order arava order atacand order augmentin order avandia order avapro order avelox order avodart order bactrim ds order clarinex order combivir order coumadin order cozaar order diovan order doxazosin order doxycycline order effexor xr order elavil order erythromycin order eskalith order evista order flomax order fosamax order hydrochlorothiazide order hydroxyzine order imitrex order lamisil order levaquin order lexapro order lotensin order lotensin-hct order metronidazole order mevacor order micardis order migranal order nexium order nolvadex order paxil order plavix order pravachol order prevacid order prilosec order proscar order protonix order renova order spironolactone order sporanox order synthroid order tenormin order topamax order toprol xl order tricor order urecholine order vaseretic order vasotec order verapamil order wellbutrin sr order zanaflex order zocor order zyban sr order benazepril hydrochloride, hydrochlorothiazide generic lotensin-hct ; brand name information to have about benazepril hydrochloride, hydrochlorothiazide generic equivalent to lotensin-hct ; amaryl information: what is amaryl and why is it prescribed and potassium. We remain Neutral 12 months ; on the sector regardless of historically low valuation multiples similar to those of the mid-1990s. Within the European pharmaceutical sector we continue to favour specific companies with profiles characterised by high cash flow output, as low-as-possible exposure to generic competition, assuming normal patent protection, inner plus outer near term pipeline aspects and sales growth through new launches and the life cycle management of recent products. Our preferred stocks are indicated below. Altana: Buy target price: EUR54 ; : Pantoprazol Protonix will help Altana deliver doubledigit earnings growth in the near term. Two late-stage product candidates will build its US presence. Aventis Buy target price: EUR76 ; : the stock's discount on the refocus on core pharmaceutical activities is appealing in the short term. Further change in the share price could be driven by confidence on the pipeline refuelled by in-licensing and or by future postdisposal M&A activity. Galen Buy target price 580p ; : the outlook for the company remains extremely positive. Sanofi-Synthlabo Buy target price: EUR70 ; : new launches and the short-term pipeline put the company at the dawn of another period of accelerating growth. The Plavkx patent challenge could reduce upside.

Plavix cases

The cardiovascular portfolios of BMS, Novartis and AstraZeneca are best positioned for high future revenue growth. while current market leaders Pfizer, Merck and Sanofi-Aventis are forecast to struggle to maintain their current market shares by 2010. Over the period 2005-2010, only the dyslipidemia market is forecast to decline in net sales. The forecast decline is due to the patent expiry of Lipitor in 2010 and the prospective generic competition for the cardiovascular market's highest selling product. The continuing dominance of Plagix and Lovenox in the thrombosis market has effectively set a high barrier to entry for new products which have to date failed to compete effectively on both efficacy and safety. Newer products may hold the key to further segmenting the thrombosis market and providing much needed competition. Thrombosis and heart failure represent the most active areas for current drug development, with hypertension now having few unmet needs. Increasing focus on these traditionally less competitive therapeutic areas is forecast to become a major trend in the cardiovascular area in the period 2005-2010 and pravachol.

Overlawyered chronicling the high cost of our legal system « moral: don't treat the morbidly obese main cathy young on the marcotte affair » plavix, lawyers and externalities trial lawyers are advertising for cases against the anti-clotting drug plavix, which worries db at medrants jan. Rank 2006 1 2 Product Lipitor Advair Pplavix Nexium Norvasc Enbrel Zyprexa Remicade Diovan Risperdal Aranesp Rituxan MabThera Protonix Pantozol Effexor Singulair Seroquel Procrit Eprex Cozaar Hyzaar Fosamax Herceptin Lovenox Zocor Neulasta Prevacid Avandia Pariet Glivec Ambien Epogen Zyrtec Actos Aprovel Avapro Avastin Taxotere Eloxatin Zoloft Tamiflu Lexapro Lantus Humira Celebrex Crestor Topamax Aricept Prevnar Vytorin Blopress Zetia Lamictal Seloken Company Pfizer Astellas GlaxoSmithKline BMS sanofi-aventis AstraZeneca Pfizer Amgen Wyeth Eli Lilly J&J Schering Plough Novartis J&J Amgen Roche Wyeth Altana Wyeth Merck & Co AstraZeneca J&J Merck & Co Merck & Co Roche sanofi-aventis Merck & Co Amgen TAP GlaxoSmithKline Eisai J&J Novartis sanofi-aventis Amgen Pfizer UCB others Takeda BMS sanofi-aventis Roche sanofi-aventis sanofi-aventis Pfizer Roche Forest sanofi-aventis Abbott Pfizer AstraZeneca J&J Eisai Wyeth Merck Schering Plough Takeda Merck Schering Plough GlaxoSmithKline AstraZeneca Sales $'m 13, 736 6, Growth % 5.7 11.7 4.5 ; 11.8 3.4 18.4 ; 4.1 1.8 ; 81.9 14.8 36.1 ; 18.4 4.0 6.6 ; 67.8 11.9 38.6 and prednisone. Highly Selective Inhibition of Cdk4 6 with Pyrido[2, 3-d]pyrimidin-7-ones" Scott N. VanderWel, 1 Patricia J. Harvey, 2 Derek J. Sheehan, 1 Joseph Repine, 1 Paul R. Keller, 2 R. John Booth, 1 John Quin III, 1 Dennis J. McNamara, 1 Hairong Zhou, 1 Ellen M. Dobrusin, 1 Alexander J. Bridges, 1 Wilbur R. Leopold, 2 David W. Fry, 2 Joanne Brodfuefrer, 3 Tong Zhu, 3 and Peter L. Toogood1. 1 ; Medicinal Chemistry, 2 ; Cancer Research, 3 ; Pharmacokinetics, Dynamics and Metabolism, PGRD Michigan Laboratories, Pfizer Inc, Ann Arbor, MI 48105. Cyclin-dependent kinases Cdks ; are regulators of cell proliferation. This group presented their work on an inhibitor of Cdk4. They anticipate that inhibition of Cdk4 will provide a relatively non-toxic approach to tumor growth inhibition. This work was a continuation of previous work which identified PD 0205606, Figure 1, as a potent inhibitor of Cdk4. PD 02005606 was potent but it lacked selectivity versus other Cdks. Since SAR around the C2 and N8 of PD 02005606 had been explored, an examination of the SAR around C5 and C6 was performed. Figure 1. International Narcotics Control Board, on achieving balance in a national opioids control policy, which are available in 22 languages on the web site of the WHO Collaborating Centre for Policy and Communications in Cancer Care 19 ; . Also, no stricter measures should be enacted than those requested by the international drug conventions and international recommendations 20 ; on the use of opioid medicines. WHO is developing a programme to assist countries in improving access to medications controlled under the drug conventions see Box 3.7.2 ; 19 and premarin. Statement on the Governance of the Global Development Network, final report of the Working Group, December 2000, available at gdnet about gdn history statement gov . 2 Researching the Researchers: Establishing Priorities, results of a survey undertaken under auspices of the International Economic Association and the World Bank for presentation at Bonn, December 5-8, 1999, available at gdnet pdf2 surveys researching researchers, for instance, plavix prescription. RANK BY CLAIMS 1 2 3 DRUG FUROSEMIDE LIPITOR FOSAMAX METOPROLOL TARTRATE NORVASC FUROSEMIDE ATENOLOL PLAVIX CELEBREX LIPITOR XALATAN PREVACID ATENOLOL PRILOSEC PROPOXYPHENE NAPSYLATE W APAP NORVASC HYDROCHLOROTHIAZIDE TRIAMTERENE W HCTZ TOPROL XL ZOCOR TOP 20 TOTALS % OF TOTALS SS Sole Source GEN Generic BNMS Multi Source STRENGTH 40MG 10MG 70MG DRUG TYPE GEN SS SS GEN SS GEN GEN SS SS SS GEN SS GEN SS BNMS GEN SS SS NUMBER OF CLAIMS 154, 174 144, $ $ $ $ EPIC PAYMENTS 781, 262 11, RANK BY PAYMENT 123 2 7 State of New York George E. Pataki, Governor Department of Health State Office for the Aging and prempro.

Mark Rovere is a Policy Analyst in the Department of Health and Pharmaceutical Policy at The Fraser Institute. Mr Rovere has an M.A. in Political Science from the University of Windsor. He has been a co-author of numerous studies and articles for The Fraser Institute. Brett J. Skinner is the Director of Health and Pharmaceutical Policy Research and of Insurance Policy Research at The Fraser Institute and works from the Institute's Toronto office. He is a Ph.D. candidate in Public Policy and Political Science, specializing in public policy, at the University of Western Ontario in London, Ontario, where he has lectured in both the Faculty of Health Sciences and the Political Science Department. He earned a B.A. through the University of Windsor in Windsor, Ontario, and an M.A. through joint studies between the University of Windsor and Wayne State University in Detroit, Michigan. He also spent a year working as a research consultant to the Insurance Bureau of Canada in Toronto. Mr Skinner's research has been published in many major papers, articles, and opinion editorials through The Fraser Institute in Vancouver and Toronto as well as the Atlantic Institute for Market Studies in Halifax, Nova Scotia. He appears frequently as an expert in the North American media and his research and opinions have been cited in media from around the world. Mr Skinner has presented his research at government, academic, and other conferences around the world and has twice testified about his research before the Canadian House of Commons Standing Committee on Health, for example, sanofi aventis plavix.
Plavix persantine aggrenox ticlid pa: documented diagnosis of recent tiacontraindications or intolerance to plwvix for secondary prevention of tia stroke and prevacid. It stiffens up and is uncomfortable to walk. Online-free wearing older and or plvaix recovery hdl rx mouth orally and prilosec.
GUIDANCE FOR THE USE OF CLOPIDOGREL PLAVIX ; IN NHS FIFE Formulary Choice In patients with GI disturbance due to aspirin or history of ulcer * , a formulary choice of PPI should be added to aspirin in preference to trying clopidogrel. Clopidogrel should only be used first line in patients who are hypersensitive to aspirin. In patients with continued ischaemic strokes or TIAs despite aspirin, add dipyridamole m r 200mg twice daily to aspirin. In patients with recurrent TIAs or strokes despite using an aspirin dypiridamole combination or who are unable to tolerate dipyridamole mainly due to headache ; , the combination of aspirin and clopidogrel cannot currently be recommended in view of the possibility of significant increased risk of bleeding. Stroke patients already being prescribed this combination should be reviewed and treatment discussed with the stroke physician as appropriate.

About plaavix side effects

47 biological variability of biochemical markers of bone turnover in healthy women and prinivil and plavix, because aggrenox vs plavix. New york, ny 10016 plavix® is a registered trademark of sanofi-synthelabo.

Bulk prescribing of drugs is restricted to those which are prescribable under the NHS but which are not Prescription Only Medicines. Paracetamol used to be frequently prescribed on bulk prescriptions but following the introduction of restrictions in paracetamol sales in September 1998, 100 paracetamol tablets is now classed as a Prescription Only Medicine so is therefore not allowed and procardia.
Simultaneous reduction of AEL and increase of ACD and LT reflects a reduction of vitreous volume. Combining the calculated volume reduction as a result of the reduced AEL 6l ; and the effect of backward movement of the anterior vitreous surface 10 l ; the total loss of vitreous volume has been 16 l on the average. According to Quigley's theory an increase of pressure behind the vitreous e.g. choroidal swelling or scleral compression ; increases the pressure difference between the vitreous and the posterior chamber PC ; . As consequence water exits the vitreous and enters the PC. To the best of our knowledge our data are the first direct evidence for vitreous conductivity in a living eye. This model might be used to measure the vitreous conductivity in patients at risk of PACG. References : 1. Quigley HA et al. 2003 ; J Glaucoma 12: 167 2. Fatt I 1977 ; Invest Ophthalmol Vis Sci 16: 565 3. Epstein DL et al. 1979 ; J Ophthalmol 88: 1078 4. Drexler W et al. 1997 ; : Invest Ophthalmol Vis Sci 38: 1304 P024 TRANSPUPILLARY THERMOTHERAPY TTT ; INDUCES SMALL HEAT SHOCK PROTEIN HSP 27 ; AND HSP 70 IN THE OPTIC NERVE HEAD S.H. Kang1, J.M. Kim2, K.H. Park 3, Y.J. Kim1, D.M. Kim3 1 Seoul National University Hospital, Seoul, South-Korea, 2Kangbuk Samsung Hospital, Seoul, South-Korea, 3Seoul National University, Seoul, South-Korea. Mesoderm. For adult cardiac progenitor cells, work will be presented on the prospective identification of a clonogenic population of mouse cardiac Sca-1 + cells, and recent discoveries involving their potential human equivalent. Y-1. Interaction of Volatile Anesthetics with -Adrenoceptor Stimulations on L-type Ca2 + Current of Rabbit Ventricular Myocytes Liu Fan1, Sonoda, S.1, Watanabe, M.2, Kugimiya, T.1, Inada, E.1, Okada, T.2 Department of 1Anesthesiology and 2Physiology, Juntendo University School of Medicine, Tokyo, Japan Background: Volatile anesthetics suppress myocardial contractility and Ca2 + current of cardiomyocytes. The suppressive effect of volatile anesthetics on Ca2 + current is diminished in the presence of -adrenoceptor stimulation. However, the interactions of volatile anesthetics with -adrenoreceptor-mediated signal transduction have not been entirely defined. The objective of the present study was to investigate the effects of sevoflurane Sevo ; and halothane Halo ; on -adrenoceptor-mediated increase in L-type Ca2 + current ICa, L ; . Methods: ICa, L was measured with whole-cell configuration of patch clamp technique in the enzymatically isolated rabbit ventricular myocytes. The effects of 1 minimum alveolar concentration Sevo 1.7% ; and Halo 0.74% ; on the isoproterenol- ISO, 30 nM ; and forskolin- FSK, 1 M ; induced increase in ICa, L were examined. Results: Sevo and Halo significantly inhibited ICa, L by 21.21.7% and 35.01.8% respectively. In the control groups, ISO and FSK increased ICa, L to 1537.0% and 240.312.8%, respectively. ISO and FSK increased ICa, L by 237.225.4% and 328.536.3% in the presence of Sevo, respectively. In the presence of Halo, ISO and FSK increased ICa, L by 247.616.3% and 242.832.8 %, respectively. Conclusion: These results suggest that Sevo and Halo have suppressive effect on ICa, L and they enhance the effect of -adrenoceptor stimulation. However, the modulation site of Sevo may be different from that of Halo, because Sevo enhanced the effect of forskolin, which activate adenylate cyclase directly, but Halo did not. This study demonstrates that volatile anesthetics-induced modulation of -adrenergic stimulation is through several pathways. Generics have broad appeal because they can dramatically lower drug costs for purchasers.

Aspirin plavix interaction

ABSTRACT A platelet-rich clot at the site of severe coronary stenosis, plaque erosion, or a recent plaque rupture is the common etiology of acute ischemic syndromes. Thus, antiplatelet therapy is the cornerstone in the management of these conditions. Aspirin in a dose ranging from 160 to 325 mg once daily should be administered to virtually all patients. In patients with severe disease, particularly those who have no acute angiography, clopidogrel Plavix, Bristol-Myers Squibb Sanofi Pharmaceuticals ; in a dose of 75 mg once daily should add to the benefit of aspirin for up to a year after the event. Clopidogrel also is an alternative to aspirin where a true aspirin allergy exists. Intravenous platelet glycoprotein IIb IIIa receptor inhibitors demonstrated a robust benefit when used in conjunction with coronary intervention and thus far have no role in medical therapy alone. Oral platelet glycoprotein IIb IIIa receptor inhibitors are of no clinical value.

Augmentin xanax overdose augmentin buy medicine augmentin augmentin xanax overdose augmentin buy medicine augmentin bacterial infection treatments amoxicillin augmentin bactrim biaxin cephalexin cipro doxycycline erythromycin keflex levaquin penicillin zithromax stimulants adderall concerta provigil ritalin strattera anti depressants amitriptyline celexa effexor xr elavil lexapro lithium paxil prozac remeron wellbutrin zoloft antiviral treatment acyclovir amantadine tamiflu valtrex anxiety panic attack medications alprazolam ativan buspar clonazepam diazepam klonopin lorazepam oxazepam rivotril valium xanax arthritis treatments bextra lodine voltaren asthma medications foradil birth control medication alesse mircette ortho evra ortho tricyclen ortho tricyclen lo plan b triphasil yasmin blood pressure treatment aceon atenolol norvasc cancer medication femara cholesterol meds crestor lipitor vytorin zocor diabetic medication avandamet insulin metformin stomach medication aciphex bentyl detrol la prevacid prilosec protonix ranitidine hcl hair losstreatments propecia blood thinner coumadin plavix eerectile dysfunction medication cialis levitra viagra migraines headache treatments butalbital esgic plus fioricet imitrex imitrex oral muscle relaxant carisoprodol flexeril skelaxin soma zanaflex pain meds codeine darvocet hydrocodone lorcet lortab norco oxycodone percocet tramadol ultram vicodin vicoprofen zydone anti psychotic abilify zyprexa seizures medications neurontin topamax sexual disease medications acyclovir aldara condylox famvir valtrex skin care treatments accutane aphthasol atarax lamisil metronidazole nizoral protopic renova retin-a sumycin tretinoin insomnia treatment ambien rozerem sonata smoking cessation zyban thyroid hormonal treatments levothyroxine synthroid appetite suppressant adipex bontril didrex diethylpropion ionamin meridia phendimetrazine phentermine tenuate xenical best results a current page: 1 next augmentin penicillins antibiotics augmentin xanax overdose augmentin buy medicine augmentin and beta-lactamase inhibitors systemic ; augmentin penicillins antibiotics augmentin xanax overdose augmentin buy medicine augmentin and beta-lactamase inhibitors are used to treat infections caused by bacteria and plendil.
Place of discount plavix for the doctorate with over 250, 000 clients strong. RESEARCH MS, including people with relapsingremitting, secondary-progressive, and primary-progressive disease as well as some whose MS type was unknown. The tissue samples were analyzed for signs of myelin damage and repair using a variety of high-tech microscopic, staining and labeling techniques. New Myelin in Progressive MS The researchers were surprised to note that, in about 20% of the samples studied, remyelination was extensive, including in those with progressive forms of MS. The amount of remyelination ranged from sparse to nearly complete repair--and, another surprise, they found more extensive remyelination in people who had died later in life and or those who had had MS for the longest period of time. No link was found between the extent of repair and the age at onset, gender, or type of MS. John Richert, MD, executive vice president of Research and Clinical Programs for the Society, told MSConnection that more research is needed to find out why some people experienced highly efficient myelin repair while others did not. "The findings of variable rates of remyelination will be taken into consideration as we design future clinical trials of ways to stimulate myelin repair, " Dr. Richert said. The study, published in the December 2006 issue of Brain, was conducted by Drs. Peter Patrikios, Hans Lassmann, and others of the Medical University of Vienna and financed by the National Institutes of Health and the European Union, with additional support from the National MS Society's MS Lesion Project led by Dr. Claudia Lucchinetti of the Mayo Clinic ; . STUDY REFUTES MS BLOOD TEST PREDICTION Scientists world-wide have been searching for ways to predict if a person will get MS. In 2003, Austrian researchers at the University of Innsbruck thought they had found a way. The Austrian team claimed to have found levels of two antibodies--anti-MOG and anti-MBP--in blood samples taken from people with CIS that predicted who would later be diagnosed with MS. CIS stands for "clinically isolated syndrome, " meaning a single neurological attack. Not everyone who has such an attack goes on to develop MS. But a new, much larger study by Swiss and German researchers, using methods similar to the earlier study, found no correlation between anti-MOG and anti-MBP levels in blood samples and a later diagnosis of MS. The new study was published in the January 25, 2007, New England Journal of Medicine. "While the news this time is not what we wanted to hear, " said Dr. John Richert, vice president for the Society's Research and Clinical Programs, "we're still hoping to find `biomarkers' that one day will accurately predict the onset or future course of MS.
Resources if you or a loved one has suffered a stroke or heart attack while taking plavix, please file your complaint with a plavix lawyer who will evaluate your claim at no cost.

Apotex plavix bristol

Candida albicans fungemia, arimidex online, ph.d. Mba, hemangioma glans and phototherapy light. Receptor cells definition, prematurity statistics, restriction enzyme protocol and hounsfield printing bristol or red yeast rice and cholesterol.

Plavix surgery 7 days

Plavix cases, about plavix side effects, aspirin plavix interaction, apotex plavix bristol and plavix surgery 7 days. Plavixx and fish oil supplements, what if you stop taking plavix, plavix safety 2006 and plavix and kidney function or where to buy plavix.

© 2005-2008 Cheap.coolpage.biz, Inc. All rights reserved.

Main page
Language of Motifs in Rugs
Status of Weaver
Photos
My Friends